Cameron Casey

Drug pricing initiatives during the Trump presidency

4:57

Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.

DOJ enforcement update: electronic health records

2:48

Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, provides an update on the enforcement of electronic health records by the Department of Justice (DOJ).

Section 101: confusion over patentable subject matter

5:11

Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.

Behavioral sciences approach to risk management

3:43

Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.

Trade secret litigation after the Defend Trade Secrets Act

4:42

Peter Brody, Ropes & Gray IP litigation partner, discusses the Defend Trade Secrets Act (DTSA) and how it has changed the trade secret litigation landscape since it was enacted in 2016.

False Claims Act: three years after Escobar

5:21

Kirsten Mayer, Ropes & Gray litigation partner, provides an update on the False Claims Act (FCA), three years after the Supreme Court’s decision on Universal Health Services v. U.S. ex rel. Escobar.